StockData
iSpecimen Inc. logo

iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.53−0.06 (-10.57%)

Close on Nov 18, 2026Market cap $1.34MP/E –Yield –

iSpecimen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

iSpecimen's gross profit for the twelve months ending Jun 30, 2026 was -$456.94K, down 123.1% year over year. For fiscal 2025 it was $215.67K, down 94.8% from the year before. The highest annual figure on record is $5.89M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$215.67K-94.8%
FY2024Dec 31, 2024$4.18M-19.0%
FY2023Dec 31, 2023$5.16M-8.6%
FY2022Dec 31, 2022$5.65M-4.1%
FY2021Dec 31, 2021$5.89M+28.0%
FY2020Dec 31, 2020$4.60M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$68.65K-74.5%
Q1 FY2026Mar 31, 2026$71.60K-82.1%
Q4 FY2025Dec 31, 2025-$499.19K-350.5%
Q3 FY2025Sep 30, 2025-$98.00K-108.8%
Q2 FY2025Jun 30, 2025$268.96K-81.3%
Q1 FY2025Mar 31, 2025$400.23K-70.1%
Q4 FY2024Dec 31, 2024$199.24K-83.4%
Q3 FY2024Sep 30, 2024$1.11M-20.0%
Q2 FY2024Jun 30, 2024$1.44M+86.6%
Q1 FY2024Mar 31, 2024$1.34M-25.8%
Q4 FY2023Dec 31, 2023$1.20M-22.8%
Q3 FY2023Sep 30, 2023$1.39M-1.2%
Q2 FY2023Jun 30, 2023$771.51K-42.4%
Q1 FY2023Mar 31, 2023$1.80M+33.3%
Q4 FY2022Dec 31, 2022$1.55M+17.0%
Q3 FY2022Sep 30, 2022$1.40M-22.3%
Q2 FY2022Jun 30, 2022$1.34M-5.4%
Q1 FY2022Mar 31, 2022$1.35M+0.9%
Q4 FY2021Dec 31, 2021$1.33M+13.9%
Q3 FY2021Sep 30, 2021$1.80M+34.1%
Q2 FY2021Jun 30, 2021$1.41M+37.3%
Q1 FY2021Mar 31, 2021$1.34M–
Q4 FY2020Dec 31, 2020$1.16M–
Q3 FY2020Sep 30, 2020$1.35M–
Q2 FY2020Jun 30, 2020$1.03M–

More iSpecimen figures

See a number that looks wrong?